marijuana stocks

MyECheck, Inc. (MYEC)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 179   (771) 182   1,362  
Cost of Revenue 2 45
Gross Profit 179   (773) 138   1,362  
Operating Expenses
Research Development 95 139 41
Selling General and Administrative 686 383 115 38
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (602) (1,296) (18) 1,324  
Income from Continuing Operations
Total Other Income/Expenses Net (418) 3 54 (0)
Earnings Before Interest And Taxes (1,043) (1,292) 35 1,324
Interest Expense (10) 7 3
Income Before Tax (1,033) (1,300) 32 1,324
Income Tax Expense 1
Minority Interest
Net Income From Continuing Ops (892) (1,300) 32 1,324
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (1,033) (1,300) 32   1,324  
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (1,033) (1,300) 32   1,324  

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

TILT Holdings Inc. (TLLTF) To Participate in Benzinga Cannabis Capital Conference

TILT Holdings To Participate in Benzinga Cannabis Capital Conference TILT Holdings Inc.…

$PMCB CEO Addresses IND Submission Questions

PharmaCyte Biotech CEO Addresses IND Submission Questions LAGUNA HILLS, Calif., March 17,…

GT Biopharma Inc. (GTBP) Announces Approved FDA IND Transfer of Its First TriKE (OXS-3550)

GT Biopharma Announces Approved FDA IND Transfer of Its First TriKE (OXS-3550)…

Cara Therapeutics, Inc. (CARA) to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Cara Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment…